Bryologyx

0 followers

BryoLogyx is developing a new class of drugs to enhance the response rates and treatment durability of cancer immunotherapies.

Employees

1-10

Links


Org chart

Co-Founder, CEO & Director
Collapse
CFO
General Counsel
VP, Clinical Development & Logistics

Board & advisors

Co-Founder & Chairman
Co-Founder & Director
Director
Director
Director
Advisor
Advisor
Advisor
Advisor
Advisor
Advisor
Advisor
Advisor
Advisor